Price $9.10 |
Market Cap
180.1M
|
Sector Health Care |
Div. Growth
-100.00%
|
|
P/E
-
|
P/B
1.47
|
P/S
0.51
|
Dividend %
4.30%
|
|
P/CF
19.8
|
P/FCF
17.8
|
Op. Cash Flow
13.5K
|
FCF
0.5
|
|
Op. Margin
-
|
Net Margin
-4.20%
|
ROE
-11.50%
|
ROI
-11.70%
|
|
ROA
-7.10%
|
EPS Growth
-751.10%
|
Current Ratio
1.9
|
Debt/Equity
11.10%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| China Health Industries Holdin (CHHE) | $0.80 | - | - | 60.3M | Strong Buy |
| Kalvista Pharmaceuticals Inc (KALV) | $8.69 | - | - | 87.7M | Strong Buy |
| Reliv International, Inc (RELV) | $4.87 | - | - | 8.9M | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $23.53 | - | 3.50% | 24.52B | Strong Buy |
| China Pharma Holdings, Inc. (CPHI) | $0.24 | - | - | 10M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
